+298.1%
APP vs GSK
+44.4%
+253.6%
-91.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.9% | +0.5% | +3.4% | +3.9% |
| 7D | +4.6% | +1.1% | +3.4% | +4.6% |
| 30D | +56.0% | +6.3% | +49.7% | +56.2% |
| 3M | +30.8% | +1.8% | +29.0% | +30.9% |
| 6M | -9.8% | +1.7% | -11.5% | -9.7% |
| YTD | -39.3% | +6.5% | -45.8% | -39.7% |
| 1Y | -26.4% | +9.5% | -35.9% | -27.1% |
| 3Y | +887.9% | +65.3% | +822.6% | +801.8% |
| All | +298.1% | +44.4% | +253.6% | +263.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling